Nat Rev Endocrinol (2018) 14(5):27084
Real human care Not a form and a chatbot
Bit of Background These new classes of antiobesity medications (ie, the GLP-1 agonists and dual agonists), referred to in this article as weight management medications, arent really new.1-4 The basic science and pharmaceutical research and development to bring these to market began more than two decades ago when two scientists, Matthias Tschop, MD, and Richard DiMarchi, PhD, hypothesized that the actions of various gut hormones may offer safe and unprecedented weight loss
They are biological requirements
This includes its role in regulating energy levels and combating fatigue, metabolism (including insulin sensitivity), and body composition through improved muscle building and fat lipolysis. Typically, mens testosterone levels decrease as they age
Systemic liraglutide administration activated LS GLP-1R neurons, and the knockdown of GLP-1Rs in the LS mitigated the anti-obesity effects of liraglutide